American Cancer Society's report on the status of cancer disparities in the United States, 2023.
cancer
disparity
race/ethnicity
rurality
socioeconomic status
Journal
CA: a cancer journal for clinicians
ISSN: 1542-4863
Titre abrégé: CA Cancer J Clin
Pays: United States
ID NLM: 0370647
Informations de publication
Date de publication:
14 Nov 2023
14 Nov 2023
Historique:
received:
01
09
2023
accepted:
07
09
2023
medline:
14
11
2023
pubmed:
14
11
2023
entrez:
14
11
2023
Statut:
aheadofprint
Résumé
In 2021, the American Cancer Society published its first biennial report on the status of cancer disparities in the United States. In this second report, the authors provide updated data on racial, ethnic, socioeconomic (educational attainment as a marker), and geographic (metropolitan status) disparities in cancer occurrence and outcomes and contributing factors to these disparities in the country. The authors also review programs that have reduced cancer disparities and provide policy recommendations to further mitigate these inequalities. There are substantial variations in risk factors, stage at diagnosis, receipt of care, survival, and mortality for many cancers by race/ethnicity, educational attainment, and metropolitan status. During 2016 through 2020, Black and American Indian/Alaska Native people continued to bear a disproportionately higher burden of cancer deaths, both overall and from major cancers. By educational attainment, overall cancer mortality rates were about 1.6-2.8 times higher in individuals with ≤12 years of education than in those with ≥16 years of education among Black and White men and women. These disparities by educational attainment within each race were considerably larger than the Black-White disparities in overall cancer mortality within each educational attainment, ranging from 1.03 to 1.5 times higher among Black people, suggesting a major role for socioeconomic status disparities in racial disparities in cancer mortality given the disproportionally larger representation of Black people in lower socioeconomic status groups. Of note, the largest Black-White disparities in overall cancer mortality were among those who had ≥16 years of education. By area of residence, mortality from all cancer and from leading causes of cancer death were substantially higher in nonmetropolitan areas than in large metropolitan areas. For colorectal cancer, for example, mortality rates in nonmetropolitan areas versus large metropolitan areas were 23% higher among males and 21% higher among females. By age group, the racial and geographic disparities in cancer mortality were greater among individuals younger than 65 years than among those aged 65 years and older. Many of the observed racial, socioeconomic, and geographic disparities in cancer mortality align with disparities in exposure to risk factors and access to cancer prevention, early detection, and treatment, which are largely rooted in fundamental inequities in social determinants of health. Equitable policies at all levels of government, broad interdisciplinary engagement to address these inequities, and equitable implementation of evidence-based interventions, such as increasing health insurance coverage, are needed to reduce cancer disparities.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : American Cancer Society
Informations de copyright
© 2023 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society.
Références
American Cancer Society. Special report on cancer in the economically disadvantaged. American Cancer Society Subcommittee on Cancer in the Economically Disadvantaged; 1986.
Freeman HP. Cancer in the socioeconomically disadvantaged. CA Cancer J Clin. 1989;39(5):266-288. doi:10.3322/canjclin.39.5.266
Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78-93. doi:10.3322/canjclin.54.2.78
Ghafoor A, Jemal A, Cokkinides V, et al. Cancer statistics for African Americans. CA Cancer J Clin. 2002;52(6):326-341. doi:10.3322/canjclin.52.6.326
O'Brien K, Cokkinides V, Jemal A, et al. Cancer statistics for Hispanics, 2003. CA Cancer J Clin. 2003;53(4):208-226. doi:10.3322/canjclin.53.4.208
Miller KD, Ortiz AP, Pinheiro PS, et al. Cancer statistics for the US Hispanic/Latino population, 2021. CA Cancer J Clin. 2021;71(6):466-487. doi:10.3322/caac.21695
Giaquinto AN, Miller KD, Tossas KY, Winn RA, Jemal A, Siegel RL. Cancer statistics for African American/Black people 2022. CA Cancer J Clin. 2022;72(3):202-229. doi:10.3322/caac.21718
Kratzer TB, Jemal A, Miller KD, et al. Cancer statistics for American Indian and Alaska Native individuals, 2022: including increasing disparities in early onset colorectal cancer. CA Cancer J Clin. 2023;73(2):120-146. doi:10.3322/caac.21757
National Program of Cancer Registries (NPCR); Surveillance, Epidemiology and End Results (SEER) Program. SEER*Stat Database: NPCR and SEER Incidence-U.S. Cancer Statistics Public Use Research Database, 2021 Submission (2001-2019). U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Cancer Institute; 2022. Accessed August 24, 2023. www.cdc.gov/cancer/uscs/public-use
Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Mortality-All causes of death, aggregated with county, total U.S. (1990-2020) <Katrina/Rita population adjustment>-Linked to county attributes-Total U.S., 1969-2020 counties (underlying mortality data provided by the National Center for Health Statistics). National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; 2022.
Withrow DR, Berrington de Gonzalez A, Spillane S, et al. Trends in mortality due to cancer in the United States by age and county-level income, 1999-2015. J Natl Cancer Inst. 2019;111(8):863-866. doi:10.1093/jnci/djz123
Kennedy AE, Vanderpool RC, Croyle RT, Srinivasan S. An overview of the National Cancer Institute's initiatives to accelerate rural cancer control research. Cancer Epidemiol Biomarkers Prev. 2018;27(11):1240-1244. doi:10.1158/1055-9965.epi-18-0934
Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER Research Limited-Field Data, 22 Registries, November 2022 Submission (2000-2020) -Linked to county attributes-Time dependent (1990-2021) income/rurality, 1969-2021 counties. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; 2023.
Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER Research Limited-Field Data, 22 registries (excluding Illinois and Massachusetts), November 2022 Submission (2000-2020)-Linked to county attributes-Time dependent (1990-2021) income/rurality, 1969-2021 counties. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; 2023.
Espey DK, Wiggins CL, Jim MA, Miller BA, Johnson CJ, Becker TM. Methods for improving cancer surveillance data in American Indian and Alaska Native populations. Cancer. 2008;113(5 suppl):1120-1130. doi:10.1002/cncr.23724
Arias E, Xu J, Curtin S, Bastian B, Tejada-Vera B. Mortality profile of the non-Hispanic American Indian or Alaska Native population, 2019. Natl Vital Stat Rep. 2021;70(12):1-27.
National Center for Health Statistics (NCHS). National Health Interview Survey (NHIS). NHIS Data, Questionnaires, and Related Documentation. NCHS; 2023. Accessed May 17, 2023. https://www.cdc.gov/nchs/nhis/data-questionnaires-documentation.htm
Star J, Bandi P, Nargis N, et al. Updated review of major cancer risk factors and screening test use in the United States, with a focus on changes during the COVID-19 pandemic. Cancer Epidemiol Biomarkers Prev. 2023;32(7):879-888. doi:10.1158/1055-9965.epi-23-0114
Stierman B, Afful J, Carroll MD, et al. National Health and Nutrition Examination Survey 2017-March 2020 Prepandemic Data Files-Development of Files and Prevalence Estimates for Selected Health Outcomes. National Health Statistics Reports. No. 158. National Center for Health Statistics; 2021.
Fedewa SA, Bandi P, Smith RA, Silvestri GA, Jemal A. Lung cancer screening rates during the COVID-19 pandemic. Chest. 2022;161(2):586-589. doi:10.1016/j.chest.2021.07.030
Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006;15(6):547-569. doi:10.1177/0962280206070621
Centers for Disease Control and Prevention (CDC). United States Cancer Statistics (USCS). Suppression of Rates and Counts. CDC: 2023. Accessed August 30, 2023. https://www.cdc.gov/cancer/uscs/technical_notes/stat_methods/suppression.htm
Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31-54. doi:10.3322/caac.21440
Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48. doi:10.3322/caac.21763
Albain KS, Gray RJ, Makower DF, et al. Race, ethnicity, and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer in the randomized TAILORx trial. J Natl Cancer Inst. 2021;113(4):390-399. doi:10.1093/jnci/djaa148
Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524-541. doi:10.3322/caac.21754
Ma J, Jemal A, Fedewa SA, et al. The American Cancer Society 2035 challenge goal on cancer mortality reduction. CA Cancer J Clin. 2019;69(5):351-362. doi:10.3322/caac.21564
Islami F, Guerra CE, Minihan A, et al. American Cancer Society's report on the status of cancer disparities in the United States, 2021. CA Cancer J Clin. 2022;72(2):112-143. doi:10.3322/caac.21703
Islami F, Marlow EC, Zhao J, et al. Person-years of life lost and lost earnings from cigarette smoking-attributable cancer deaths, United States, 2019. Int J Cancer. 2022;151(12):2095-2106. doi:10.1002/ijc.34217
American Cancer Society Cancer Action Network. How do you measure up? A progress report on state legislative activity to reduce cancer incidence and mortality. 17th ed. American Cancer Society; 2019. Accessed August 30, 2023. https://www.fightcancer.org/how-do-you-measure-up
Kaiser Family Foundation. Status of State Medicaid Expansion Decisions: Interactive Map. Kaiser Family Foundation; 2023. Accessed August 24, 2023. https://www.kff.org/medicaid/issue-brief/status-of-state-medicaid-expansion-decisions-interactive-map/
Alcaraz KI, Wiedt TL, Daniels EC, Yabroff KR, Guerra CE, Wender RC. Understanding and addressing social determinants to advance cancer health equity in the United States: a blueprint for practice, research, and policy. CA Cancer J Clin. 2020;70(1):31-46. doi:10.3322/caac.21586
Solar O, Irwin A. A conceptual framework for action on the social determinants of health. Social Determinants of Health Discussion Paper 2 (Policy and Practice). World Health Organization; 2010.
Islami F, Siegel RL, Jemal A. The changing landscape of cancer in the USA-opportunities for advancing prevention and treatment. Nat Rev Clin Oncol. 2020;17(10):631-649. doi:10.1038/s41571-020-0378-y
World Health Organization (WHO). Social determinants of health. WHO; 2023. Accessed June 14, 2023. https://www.who.int/health-topics/social-determinants-of-health#tab=tab_1
Bailey ZD, Feldman JM, Bassett MT. How structural racism works-racist policies as a root cause of U.S. racial health inequities. N Engl J Med. 2020;384(8):768-773. doi:10.1056/nejmms2025396
Venkataramani AS, O'Brien R, Whitehorn GL, Tsai AC. Economic influences on population health in the United States: toward policymaking driven by data and evidence. PLoS Med. 2020;17(9):e1003319. doi:10.1371/journal.pmed.1003319
LeMasters K, Renson A, Edwards JK, et al. Inequities in life course criminal legal system sanctions: measuring cumulative involvement. Ann Epidemiol. 2022;76:83-90. doi:10.1016/j.annepidem.2022.10.007
Krieger N, Wright E, Chen JT, Waterman PD, Huntley ER, Arcaya M. Cancer stage at diagnosis, historical redlining, and current neighborhood characteristics: breast, cervical, lung, and colorectal cancers, Massachusetts, 2001-2015. Am J Epidemiol. 2020;189(10):1065-1075. doi:10.1093/aje/kwaa045
Collin LJ, Gaglioti AH, Beyer KM, et al. Neighborhood-level redlining and lending bias are associated with breast cancer mortality in a large and diverse metropolitan area. Cancer Epidemiol Biomarkers Prev. 2021;30(1):53-60. doi:10.1158/1055-9965.epi-20-1038
Neil B, Chang AC, Dettling LJ, Hsu JW. Disparities in wealth by race and ethnicity in the 2019 Survey of Consumer Finances, FEDS Notes No. 2020-09-28-2. Board of Governors of the Federal Reserve System; 2020. Accessed August 30, 2023. https://www.federalreserve.gov/econres/notes/feds-notes/disparities-in-wealth-by-race-and-ethnicity-in-the-2019-survey-of-consumer-finances-20200928.html
Shkembi A, Smith LM, Neitzel RL. Linking environmental injustices in Detroit, MI to institutional racial segregation through historical federal redlining. J Expo Sci Environ Epidemiol. Published online December 21, 2022. doi:10.1038/s41370-022-00512-y
Kodros JK, Bell ML, Dominici F, et al. Unequal airborne exposure to toxic metals associated with race, ethnicity, and segregation in the USA. Nat Commun. 2022;13(1):10. doi:10.1038/s41467-022-33372-z
Brazil N. Environmental inequality in the neighborhood networks of urban mobility in US cities. Proc Natl Acad Sci U S A. 2022;119(17):e2117776119. doi:10.1073/pnas.2117776119
Querdibitty CD, Campbell J, Wetherill MS, Salvatore AL. Geographic and social economic disparities in the risk of exposure to ambient air respiratory toxicants at Oklahoma licensed early care and education facilities. Environ Res. 2023;218:114975. doi:10.1016/j.envres.2022.114975
Westrick AC, Bailey ZD, Schlumbrecht M, et al. Residential segregation and overall survival of women with epithelial ovarian cancer. Cancer. 2020;126(16):3698-3707. doi:10.1002/cncr.32989
Shariff-Marco S, Sangaramoorthy M, Ellis L, et al. Impact of racial/ethnic discrimination on quality of life among breast cancer survivors. Am J Epidemiol. 2023;192(3):367-376.
Poulson MR, Papageorge MV, LaRaja AS, Kenzik KM, Sachs TE. Socioeconomic mediation of racial segregation in pancreatic cancer treatment and outcome disparities. Ann Surg. 2022;278(2):246-252. doi:10.1097/sla.0000000000005543
Zhang L, Gong R, Shi L, et al. Association of residential racial and economic segregation with cancer mortality in the US. JAMA Oncol. 2023;9(1):122-126. doi:10.1001/jamaoncol.2022.5382
Mueller JT, Brooks MM, Pacas JD. Cost of living variation, nonmetropolitan America, and implications for the Supplemental Poverty Measure. Popul Res Policy Rev. 2022;41(4):1501-1523. doi:10.1007/s11113-022-09702-w
Jemal A, Robbins AS, Lin CC, et al. Factors that contributed to Black-White disparities in survival among nonelderly women with breast cancer between 2004 and 2013. J Clin Oncol. 2018;36(1):14-24. doi:10.1200/jco.2017.73.7932
Sineshaw HM, Ng K, Flanders WD, Brawley OW, Jemal A. Factors that contribute to differences in survival of Black vs White patients with colorectal cancer. Gastroenterology. 2018;154(4):906-915.e7. doi:10.1053/j.gastro.2017.11.005
Fletcher SA, Cole AP, Lu C, et al. The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years. Cancer. 2020;126(3):496-505. doi:10.1002/cncr.32562
Zhao J, Han X, Nogueira L, et al. Health insurance status and cancer stage at diagnosis and survival in the United States. CA Cancer J Clin. 2022;72(6):542-560. doi:10.3322/caac.21732
Smith RA, Andrews KS, Brooks D, et al. Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019;69(3):184-210. doi:10.3322/caac.21557
Shastri SS, Talluri R, Shete S. Disparities in secondhand smoke exposure in the United States: National Health and Nutrition Examination Survey 2011-2018. JAMA Intern Med. 2021;181(1):134-137. doi:10.1001/jamainternmed.2020.3975
Sung H, Siegel RL, Rosenberg PS, Jemal A. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health. 2019;4(3):e137-e147. doi:10.1016/s2468-2667(18)30267-6
Jemal A, Ward EM, Johnson CJ, et al. Annual Report to the Nation on the Status of Cancer, 1975-2014, featuring survival. J Natl Cancer Inst. 2017;109(9):109. doi:10.1093/jnci/djx030
Bauer C, Zhang K, Xiao Q, Lu J, Hong YR, Suk R. County-level social vulnerability and breast, cervical, and colorectal cancer screening rates in the US, 2018. JAMA Netw Open. 2022;5(9):e2233429. doi:10.1001/jamanetworkopen.2022.33429
Mohl JT, Ciemins EL, Miller-Wilson LA, Gillen A, Luo R, Colangelo F. Rates of follow-up colonoscopy after a positive stool-based screening test result for colorectal cancer among health care organizations in the US, 2017-2020. JAMA Netw Open. 2023;6(1):e2251384. doi:10.1001/jamanetworkopen.2022.51384
Hughes DR, Espinoza W, Fein S, Rula EY, McGinty G. Patient cost-sharing and utilization of breast cancer diagnostic imaging by patients undergoing subsequent testing after a screening mammogram. JAMA Netw Open. 2023;6(3):e234893. doi:10.1001/jamanetworkopen.2023.4893
Khoong EC, Rivadeneira NA, Pacca L, et al. Extent of follow-up on abnormal cancer screening in multiple California public hospital systems: a retrospective review. J Gen Intern Med. 2023;38(1):21-29. doi:10.1007/s11606-022-07657-4
Asiri IM, Chen RC, Young HN, et al. Race and prostate specific antigen surveillance testing and monitoring 5-years after definitive therapy for localized prostate cancer. Prostate Cancer Prostatic Dis. 2021;24(4):1093-1102. doi:10.1038/s41391-021-00365-w
Tsai MH, Bevel MS, Andrzejak SE, Moore JX. Receipt of follow-up care plans on colorectal cancer screening among breast, prostate, and lung cancer survivors. J Cancer Surviv. Published online December 27, 2022. doi:10.1007/s11764-022-01309-6
Advani P, Advani S, Nayak P, et al. Racial/ethnic disparities in use of surveillance mammogram among breast cancer survivors: a systematic review. J Cancer Surviv. 2022;16(3):514-530. doi:10.1007/s11764-021-01046-2
Rendle KA, Sarma EA, Quaife SL, et al. Cancer symptom recognition and anticipated delays in seeking care among U.S. adults. Am J Prev Med. 2019;57(1):e1-e9. doi:10.1016/j.amepre.2019.02.021
Guadagnolo BA, Petereit DG, Coleman CN. Cancer care access and outcomes for American Indian populations in the United States: challenges and models for progress. Semin Radiat Oncol. 2017;27(2):143-149. doi:10.1016/j.semradonc.2016.11.006
Bailey ZD, Krieger N, Agenor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453-1463. doi:10.1016/s0140-6736(17)30569-x
Fang P, He W, Gomez D, et al. Racial disparities in guideline-concordant cancer care and mortality in the United States. Adv Radiat Oncol. 2018;3:221-229. doi:10.1016/j.adro.2018.04.013
Bitterman DS, Bona K, Laurie F, et al. Race disparities in proton radiotherapy use for cancer treatment in patients enrolled in Children's Oncology Group trials. JAMA Oncol. 2020;6(9):1465-1468. doi:10.1001/jamaoncol.2020.2259
Zavala VA, Bracci PM, Carethers JM, et al. Cancer health disparities in racial/ethnic minorities in the United States. Br J Cancer. 2021;124(2):315-332. doi:10.1038/s41416-020-01038-6
Hao S, Snyder RA, Irish W, Parikh AA. Association of race and health insurance in treatment disparities of colon cancer: a retrospective analysis utilizing a national population database in the United States. PLoS Med. 2021;18(10):e1003842. doi:10.1371/journal.pmed.1003842
Ermer T, Canavan ME, Maduka RC, et al. Association between Food and Drug Administration approval and disparities in immunotherapy use among patients with cancer in the US. JAMA Netw Open. 2022;5(6):e2219535. doi:10.1001/jamanetworkopen.2022.19535
Sineshaw HM, Sahar L, Osarogiagbon RU, Flanders WD, Yabroff KR, Jemal A. County-level variations in receipt of surgery for early-stage non-small cell lung cancer in the United States. Chest. 2020;157(1):212-222. doi:10.1016/j.chest.2019.09.016
Blom EF, Ten Haaf K, Arenberg DA, de Koning HJ. Disparities in receiving guideline-concordant treatment for lung cancer in the United States. Ann Am Thorac Soc. 2020;17(2):186-194. doi:10.1513/annalsats.201901-094oc
Poulson M, Cornell E, Madiedo A, et al. The impact of racial residential segregation on colorectal cancer outcomes and treatment. Ann Surg. 2021;273(6):1023-1030. doi:10.1097/sla.0000000000004653
Herb J, Dunham L, Stitzenberg K. A comparison of area-level socioeconomic status indices in colorectal cancer care. J Surg Res. 2022;280:304-311. doi:10.1016/j.jss.2022.07.036
LeMasters T, Madhavan SS, Sambamoorthi U, Hazard-Jenkins HW, Kelly KM, Long D. Receipt of guideline-concordant care among older women with stage I-III breast cancer: a population-based study. J Natl Compr Canc Netw. 2018;16(6):703-710. doi:10.6004/jnccn.2018.7004
Parekh A, Fu W, Hu C, et al. Impact of race, ethnicity, and socioeconomic factors on receipt of radiation after breast conservation surgery: analysis of the National Cancer Database. Breast Cancer Res Treat. 2018;172(1):201-208. doi:10.1007/s10549-018-4881-0
Noel M, Fiscella K. Disparities in pancreatic cancer treatment and outcomes. Health Equity. 2019;3(1):532-540. doi:10.1089/heq.2019.0057
Hamad A, DePuccio M, Reames BN, et al. Disparities in stage-specific guideline-concordant cancer-directed treatment for patients with pancreatic adenocarcinoma. J Gastrointest Surg. 2021;25(11):2889-2901. doi:10.1007/s11605-021-04984-5
Bregar AJ, Alejandro Rauh-Hain J, Spencer R, et al. Disparities in receipt of care for high-grade endometrial cancer: a National Cancer Data Base analysis. Gynecol Oncol. 2017;145:114-121. doi:10.1016/j.ygyno.2017.03.332
Kaspers M, Llamocca E, Quick A, Dholakia J, Salani R, Felix AS. Black and Hispanic women are less likely than White women to receive guideline-concordant endometrial cancer treatment. Am J Obstet Gynecol. 2020;223(3):398.e1-398.e18. doi:10.1016/j.ajog.2020.02.041
Karanth S, Fowler ME, Mao X, et al. Race, socioeconomic status, and health-care access disparities in ovarian cancer treatment and mortality: systematic review and meta-analysis. JNCI Cancer Spectr. 2019;3(4):pkz084. doi:10.1093/jncics/pkz084
Montes de Oca MK, Wilson LE, Previs RA, et al. Healthcare access dimensions and guideline-concordant ovarian cancer treatment: SEER-Medicare analysis of the ORCHiD study. J Natl Compr Canc Netw. 2022;20(11):1255-1266.e1211. doi:10.6004/jnccn.2022.7055
Savitch SL, Grenda TR, Scott W, et al. Racial disparities in rates of surgery for esophageal cancer: a study from the National Cancer Database. J Gastrointest Surg. 2021;25(3):581-592. doi:10.1007/s11605-020-04653-z
Vyfhuis MAL, Suzuki I, Bentzen SM, Cullen KJ, Goloubeva OG. Adherence to guideline-concordant care and its effect on survival in Black patients with head and neck cancers: a SEER-Medicare analysis. Oncologist. 2021;26(7):579-587. doi:10.1002/onco.13763
Reeder-Hayes KE, Mayer SE, Olshan AF, et al. Race and delays in breast cancer treatment across the care continuum in the Carolina Breast Cancer Study. Cancer. 2019;125(22):3985-3992. doi:10.1002/cncr.32378
Song JH, Kantor O, Mittendorf EA, King TA, Minami CA. Race and site of care impact treatment delays in older women with non-metastatic breast cancer. Ann Surg Oncol. 2022;29(7):4103-4114. doi:10.1245/s10434-022-11543-y
Sood N, Liu Y, Lian M, et al. Association of endocrine therapy initiation timeliness with adherence and continuation in low-income women with breast cancer. JAMA Netw Open. 2022;5(8):e2225345. doi:10.1001/jamanetworkopen.2022.25345
Grady I, Grady S, Chanisheva N. Long-term cost of breast cancer treatment to the United States Medicare program by stage at diagnosis. Eur J Health Econ. 2021;22(9):1365-1370. doi:10.1007/s10198-021-01315-y
Shih YT, Xu Y, Bradley C, Giordano SH, Yao J, Yabroff KR. Costs around the first year of diagnosis for 4 common cancers among the privately insured. J Natl Cancer Inst. 2022;114(10):1392-1399. doi:10.1093/jnci/djac141
Rosenthal MB. The growing problem of out-of-pocket costs and affordability in employer-sponsored insurance. JAMA. 2021;326(4):305-306. doi:10.1001/jama.2021.11166
Kaiser Family Foundation. 2022 Employer Health Benefits Survey. Section 7: Employee Cost Sharing; Kaiser Family Foundation; 2023. Accessed April 28, 2023. https://www.kff.org/report-section/ehbs-2022-section-7-employee-cost-sharing/
Han X, Zhao J, Zheng Z, de Moor JS, Virgo KS, Yabroff KR. Medical financial hardship intensity and financial sacrifice associated with cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2020;29(2):308-317. doi:10.1158/1055-9965.epi-19-0460
Hastert TA, Ruterbusch JJ, Abrams J, et al. Financial hardship by age at diagnosis including in young adulthood among African American cancer survivors. Cancer Epidemiol Biomarkers Prev. 2022;31(4):876-884. doi:10.1158/1055-9965.epi-21-0739
Banegas MP, Guy GP Jr, de Moor JS, et al. For working-age cancer survivors, medical debt and bankruptcy create financial hardships. Health Aff (Millwood). 2016;35(1):54-61. doi:10.1377/hlthaff.2015.0830
Yabroff KR, Dowling EC, Guy GP Jr, et al. Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol. 2016;34(3):259-267. doi:10.1200/jco.2015.62.0468
Yabroff KR, Han X, Song W, et al. Association of medical financial hardship and mortality among cancer survivors in the United States. J Natl Cancer Inst. 2022;114(6):863-870. doi:10.1093/jnci/djac044
Kehl KL, Lathan CS, Johnson BE, Schrag D. Race, poverty, and initial implementation of precision medicine for lung cancer. J Natl Cancer Inst. 2019;111(4):431-434. doi:10.1093/jnci/djy202
Wilson LE, Greiner MA, Altomare I, Rotter J, Dinan MA. Rapid rise in the cost of targeted cancer therapies for Medicare patients with solid tumors from 2006 to 2015. J Geriatr Oncol. 2021;12(3):375-380. doi:10.1016/j.jgo.2020.11.007
Osarogiagbon RU, Sineshaw HM, Unger JM, Acuna-Villaorduna A, Goel S. Immune-based cancer treatment: addressing disparities in access and outcomes. Am Soc Clin Oncol Educ Book. 2021;41:1-13. doi:10.1200/edbk_323523
Harrison S, Judd J, Chin S, Ragin C. Disparities in lung cancer treatment. Curr Oncol Rep. 2022;24(2):241-248. doi:10.1007/s11912-022-01193-4
Fu SJ, Rose L, Dawes AJ, Knowlton LM, Ruddy KJ, Morris AM. Out-of-pocket costs among patients with a new cancer diagnosis enrolled in high-deductible health plans vs traditional insurance. JAMA Netw Open. 2021;4(12):e2134282. doi:10.1001/jamanetworkopen.2021.34282
Mahashabde R, Li C. Nonelderly adult cancer survivors in high deductible health plan: healthcare expenditure, utilization and access. Healthcare (Basel). 2021;9:1090. doi:10.3390/healthcare9091090
Zheng Z, Jemal A, Banegas MP, Han X, Yabroff KR. High-deductible health plans and cancer survivorship: what is the association with access to care and hospital emergency department use? J Oncol Pract. 2019;15(11):e957-e968. doi:10.1200/jop.18.00699
Yabroff KR, Reeder-Hayes K, Zhao J, et al. Health insurance coverage disruptions and cancer care and outcomes: systematic review of published research. J Natl Cancer Inst. 2020;112(7):671-687. doi:10.1093/jnci/djaa048
Glied S, Swartz K. Stopping the “Medicaid churn”-addressing Medicaid coverage after the COVID-19 public health emergency ends. JAMA Health Forum. 2022;3(11):e224814. doi:10.1001/jamahealthforum.2022.4814
Bhanja A, Lee D, Gordon SH, Allen H, Sommers BD. Comparison of income eligibility for Medicaid vs Marketplace coverage for insurance enrollment among low-income US adults. JAMA Health Forum. 2021;2(6):e210771. doi:10.1001/jamahealthforum.2021.0771
Roberts TJ, Kesselheim AS, Avorn J. Variation in use of lung cancer targeted therapies across state Medicaid programs, 2020-2021. JAMA Netw Open. 2023;6(1):e2252562. doi:10.1001/jamanetworkopen.2022.52562
Yabroff KR, Gansler T, Wender RC, Cullen KJ, Brawley OW. Minimizing the burden of cancer in the United States: goals for a high-performing health care system. CA Cancer J Clin. 2019;69(3):166-183. doi:10.3322/caac.21556
Esnaola NF, Ford ME. Racial differences and disparities in cancer care and outcomes: where's the rub? Surg Oncol Clin N Am. 2012;21(3):417-437. doi:10.1016/j.soc.2012.03.012
Landon BE, Onnela JP, Meneades L, O'Malley AJ, Keating NL. Assessment of racial disparities in primary care physician specialty referrals. JAMA Netw Open. 2021;4(1):e2029238. doi:10.1001/jamanetworkopen.2020.29238
Dimick J, Ruhter J, Sarrazin MV, Birkmeyer JD. Black patients more likely than whites to undergo surgery at low-quality hospitals in segregated regions. Health Aff (Millwood). 2013;32(6):1046-1053. doi:10.1377/hlthaff.2011.1365
Wakefield D. Cancer care disparities in the LGBT community. Curr Opin Support Palliat Care. 2021;15:174-179. doi:10.1097/spc.0000000000000557
Lin CC, Bruinooge SS, Kirkwood MK, et al. Association between geographic access to cancer care, insurance, and receipt of chemotherapy: geographic distribution of oncologists and travel distance. J Clin Oncol. 2015;33(28):3177-3185. doi:10.1200/jco.2015.61.1558
Onega T, Alford-Teaster J, Wang F. Population-based geographic access to parent and satellite National Cancer Institute cancer center facilities. Cancer. 2017;123(17):3305-3311. doi:10.1002/cncr.30727
Levit LA, Byatt L, Lyss AP, et al. Closing the rural cancer care gap: three institutional approaches. JCO Oncol Pract. 2020;16(7):422-430. doi:10.1200/op.20.00174
Shalowitz DI, Hung P, Zahnd WE, Eberth J. Pre-pandemic geographic access to hospital-based telehealth for cancer care in the United States. PLoS One. 2023;18(1):e0281071. doi:10.1371/journal.pone.0281071
Zahnd WE, Fogleman AJ, Jenkins WD. Rural-urban disparities in stage of diagnosis among cancers with preventive opportunities. Am J Prev Med. 2018;54(5):688-698. doi:10.1016/j.amepre.2018.01.021
Probst JC, Zahnd WE, Hung P, Eberth JM, Crouch EL, Merrell MA. Rural-urban mortality disparities: variations across causes of death and race/ethnicity, 2013-2017. Am J Public Health. 2020;110(9):1325-1327. doi:10.2105/ajph.2020.305703
Owsley KM, Bradley CJ. Access to oncology services in rural areas: influence of the 340B drug pricing program. Health Aff (Millwood). 2023;42(6):785-794. doi:10.1377/hlthaff.2022.01640
Orwat J, Caputo N, Key W, De Sa J. Comparing rural and urban cervical and breast cancer screening rates in a privately insured population. Soc Work Public Health. 2017;32(5):311-323. doi:10.1080/19371918.2017.1289872
Wang H, Roy S, Kim J, Farazi PA, Siahpush M, Su D. Barriers of colorectal cancer screening in rural USA: a systematic review. Rural Remote Health. 2019;19:5181. doi:10.22605/rrh5181
Wiese D, Islami F, Henry KA. Changes in geographic accessibility to mammography by state and rural-urban status, United States, 2006-2022. J Natl Cancer Inst. 2023;115(3):337-340. doi:10.1093/jnci/djac217
McCarthy S, Moore D, Smedley WA, et al. Impact of rural hospital closures on health-care access. J Surg Res. 2021;258:170-178. doi:10.1016/j.jss.2020.08.055
Zahnd WE, Hung P, Shi SK, et al. Availability of hospital-based cancer services before and after rural hospital closure, 2008-2017. J Rural Health. 2023;39(2):416-425. doi:10.1111/jrh.12716
Islami F, Wiese D, Marlow EC, et al. Progress in reducing cancer mortality in the United States by congressional district, 1996-2003 to 2012-2020. Cancer. 2023;129(16):2522-2531. doi:10.1002/cncr.34808
Federal Communications Commission (FCC). Fourteenth Broadband Deployment Report. FCC 21-18. FCC; 2021. Accessed May 1, 2023. https://docs.fcc.gov/public/attachments/FCC-21-18A1.pdf
Yao R, Zhang W, Evans R, Cao G, Rui T, Shen L. Inequities in health care services caused by the adoption of digital health technologies: scoping review. J Med Internet Res. 2022;24(3):e34144. doi:10.2196/34144
Cousins MM, Van Til M, Steppe E, et al. Age, race, insurance type, and digital divide index are associated with video visit completion for patients seen for oncologic care in a large hospital system during the COVID-19 pandemic. PLoS One. 2022;17(11):e0277617. doi:10.1371/journal.pone.0277617
Centers for Disease Control and Prevention (CDC); United States Cancer Statistics. Highlights from 2020 Mortality and Incidence with Comparison to 2019 Incidence to Assess the Effect of the COVID-19 Pandemic. U.S. Cancer Statistics Data Briefs, No. 35, June 2023. CDC; 2023. Accessed June 29, 2023. https://www.cdc.gov/cancer/uscs/about/data-briefs/no35-USCS-highlights-2020.htm
Han X, Yang NN, Nogueira L, et al. Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment. Lancet Oncol. 2023;24(8):855-867. doi:10.1016/s1470-2045(23)00293-0
Bakouny Z, Paciotti M, Schmidt AL, Lipsitz SR, Choueiri TK, Trinh QD. Cancer screening tests and cancer diagnoses during the COVID-19 pandemic. JAMA Oncol. 2021;7(3):458-460. doi:10.1001/jamaoncol.2020.7600
Yabroff KR, Wu XC, Negoita S, et al. Association of the COVID-19 pandemic with patterns of statewide cancer services. J Natl Cancer Inst. 2022;114(6):907-909. doi:10.1093/jnci/djab122
Marlow EC, Jemal A, Thomson B, et al. Mortality by education before and during the COVID-19 pandemic, U.S., 2017-2020. Am J Prev Med. 2023;64(1):105-116. doi:10.1016/j.amepre.2022.08.015
Zhao J, Mao Z, Fedewa SA, et al. The Affordable Care Act and access to care across the cancer control continuum: a review at 10 years. CA Cancer J Clin. 2020;70(3):165-181. doi:10.3322/caac.21604
McCullough ML, Chantaprasopsuk S, Islami F, et al. Association of socioeconomic and geographic factors with diet quality in US adults. JAMA Netw Open. 2022;5(6):e2216406. doi:10.1001/jamanetworkopen.2022.16406
Rees-Punia E, Kirkland EG, Rittase MH, et al. Racial, ethnic, and nativity disparities in physical activity and sedentary time among Cancer Prevention Study-3 participants. Med Sci Sports Exerc. 2022;54(7):1139-1146. doi:10.1249/mss.0000000000002891
Islami F, Fedewa SA, Thomson B, Nogueira L, Yabroff KR, Jemal A. Association between disparities in intergenerational economic mobility and cause-specific mortality among Black and White persons in the United States. Cancer Epidemiol. 2021;74:101998. doi:10.1016/j.canep.2021.101998
Zheng Z, Fedewa SA, Islami F, et al. Paid sick leave among working cancer survivors and its associations with use of preventive services in the United States. J Natl Compr Canc Netw. 2022;20(11):1244-1254.e3. doi:10.6004/jnccn.2022.7058
Fan Q, Keene DE, Banegas MP, et al. Housing insecurity among patients with cancer. J Natl Cancer Inst. 2022;114(12):1584-1592. doi:10.1093/jnci/djac136
Zhao J, Han X, Zheng Z, et al. Incarceration history and health insurance and coverage changes in the U.S. Am J Prev Med. 2023;64(3):334-342. doi:10.1016/j.amepre.2022.09.023
Fedewa SA, Yabroff KR, Smith RA, Goding Sauer A, Han X, Jemal A. Changes in breast and colorectal cancer screening after Medicaid expansion under the Affordable Care Act. Am J Prev Med. 2019;57(1):3-12. doi:10.1016/j.amepre.2019.02.015
Ji X, Hu X, Castellino SM, Mertens AC, Yabroff KR, Han X. Narrowing insurance disparities among children and adolescents with cancer following the Affordable Care Act. JNCI Cancer Spectr. 2022;6(1):pkac006. doi:10.1093/jncics/pkac006
Han X, Zhao J, Yabroff KR, Johnson CJ, Jemal A. Association between Medicaid expansion under the Affordable Care Act and survival among newly diagnosed cancer patients. J Natl Cancer Inst. 2022;114(8):1176-1185. doi:10.1093/jnci/djac077
Ji X, Shi KS, Mertens AC, et al. Survival in young adults with cancer is associated with Medicaid expansion through the Affordable Care Act. J Clin Oncol. 2023;41(10):1909-1920. doi:10.1200/jco.22.01742
American Cancer Society (ACS). VOICES of Black Women. ACS; 2023. Accessed September 18, 2023. https://voices.cancer.org
American Cancer Society. ACS research priority areas; 2023. Accessed May 19, 2023. https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/extramural-priority-research-areas.html
American Cancer Society (ACS). Cancer Disparities ACS Research Highlights. ACS; 2023. Accessed May 19, 2023. https://www.cancer.org/research/acs-research-highlights/cancer-health-disparities-research.html
American Cancer Society (ACS). ACS Center for Diversity in Cancer Research (DICR) Training. ACS; 2023. Accessed May 19, 2023. https://www.cancer.org/research/acs-center-for-diversity-in-cancer-research-training.html
American Cancer Society (ACS). RFA: Cancer Health Equity Research Centers. ACS; 2023. Accessed May 19, 2023. https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/rfa-cancer-equity-research-centers.html
Liang S, Kegler MC, Cotter M, et al. Integrating evidence-based practices for increasing cancer screenings in safety net health systems: a multiple case study using the Consolidated Framework for Implementation Research. Implement Sci. 2016;11(1):109. doi:10.1186/s13012-016-0477-4
Knudsen KE, Wiatrek DE, Greenwald J, McComb K, Sharpe K. The American Cancer Society and patient navigation: past and future perspectives. Cancer. 2022;128(suppl 13):2673-2677. doi:10.1002/cncr.34206
American Cancer Society (ACS). The National HPV Vaccination Roundtable. ACS; 2023. Accessed June 21, 2023. https://hpvroundtable.org/
American Cancer Society (ACS). National Colorectal Cancer Roundtable. ACS; 2023. Accessed June 21, 2023. https://nccrt.org
American Cancer Society (ACS). National Lung Cancer Roundtable. ACS; 2023. Accessed June 21, 2023. https://nlcrt.org
American Cancer Society (ACS). National Breast Cancer Roundtable. ACS; 2023. Accessed August 29, 2023. https://www.nbcrt.org/
American Cancer Society (ACS). National Roundtable on Cervical Cancer. ACS; 2023. Accessed August 29, 2023. https://www.cervicalroundtable.org/
American Cancer Society (ACS). National Navigation Roundtable. ACS; 2023. Accessed June 21, 2023. https://navigationroundtable.org
American Cancer Society (ACS). How We're Providing Support. ACS; 2023. Accessed June 21, 2023. https://www.cancer.org/about-us/what-we-do/providing-support.html
American Cancer Society (ACS). Hope Lodge®. ACS; 2023. Accessed June 21, 2023. https://www.cancer.org/support-programs-and-services/patient-lodging/hope-lodge.html
American Cancer Society (ACS). Road to Recovery®. ACS; 2023. Accessed June 21, 2023. https://www.cancer.org/support-programs-and-services/road-to-recovery.html
American Cancer Society Cancer Action Network (ACS CAN). ACS CAN Supports the Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act. H.R. 5030/S. 2706. ACS; 2023. Accessed June 1, 2023. https://www.fightcancer.org/sites/default/files/docs/diverse_trials_act_factsheet_website_9.1.21.pdf
American Cancer Society Cancer Action Network (ACS CAN). Medicaid: ensuring access to affordable health care coverage for lower income cancer patients and survivors. ACS; 2019. Accessed June 14, 2023. https://www.fightcancer.org/sites/default/files/docs/resources/Medicaid%20Covers%20US_White%20Paper_Final.pdf
Kim U, Koroukian S, Statler A, Rose J. The effect of Medicaid expansion among adults from low-income communities on stage at diagnosis in those with screening-amenable cancers. Cancer. 2020;126(18):4209-4219. doi:10.1002/cncr.32895
Ji X, Castellino SM, Mertens AC, et al. Association of Medicaid expansion with cancer stage and disparities in newly diagnosed young adults. J Natl Cancer Inst. 2021;113(12):1723-1732. doi:10.1093/jnci/djab105
Kaiser Family Foundation. Health Insurance Coverage of Adults 19-64 Living in Poverty (under 100% FPL). Kaiser Family Foundation; 2021. Accessed August 7, 2023. https://www.kff.org/other/state-indicator/poor-adults/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D
Kaiser Family Foundation. State Health Facts. Population Distribution by Race/Ethnicity. Kaiser Family Foundation; 2021. Accessed May 18, 2023. https://www.kff.org/other/state-indicator/distribution-by-raceethnicity/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D
Snyder RA, Hu CY, DiBrito SR, Chang GJ. Association of Medicaid expansion with racial disparities in cancer stage at presentation. Cancer. 2022;128(18):3340-3351. doi:10.1002/cncr.34347
Centers for Disease Control and Prevention (CDC). The National Breast and Cervical Cancer Early Detection Program (NBCCEDP). About the Program. CDC; 2023. Accessed May 18, 2023. https://www.cdc.gov/cancer/nbccedp/about.htm
Hoerger TJ, Ekwueme DU, Miller JW, et al. Estimated effects of the National Breast and Cervical Cancer Early Detection Program on breast cancer mortality. Am J Prev Med. 2011;40(4):397-404. doi:10.1016/j.amepre.2010.12.017
Pollack LM, Ekwueme DU, Hung MC, Miller JW, Chang SH. Estimating the impact of increasing cervical cancer screening in the National Breast and Cervical Cancer Early Detection Program among low-income women in the USA. Cancer Causes Control. 2020;31(7):691-702. doi:10.1007/s10552-020-01314-z
Wong FL, Miller JW. Centers for Disease Control and Prevention's National Breast and Cervical Cancer Early Detection Program: increasing access to screening. J Womens Health (Larchmt). 2019;28(4):427-431. doi:10.1089/jwh.2019.7726
Tangka F, Kenny K, Miller J, Howard DH. The eligibility and reach of the National Breast And Cervical Cancer Early Detection Program after implementation of the Affordable Care Act. Cancer Causes Control. 2020;31(5):473-489. doi:10.1007/s10552-020-01286-0
Centers for Medicare & Medicaid Services (CMS). Statements by CMS Leadership on Historic Announcement of First Selected Drugs for Medicare Drug Price Negotiation. CMS; 2023. Accessed August 29, 2023. https://www.cms.gov/newsroom/press-releases/statements-cms-leadership-historic-announcement-first-selected-drugs-medicare-drug-price-negotiation
Sommers BD, Long SK, Baicker K. Changes in mortality after Massachusetts health care reform: a quasi-experimental study. Ann Intern Med. 2014;160(9):585-593. doi:10.7326/m13-2275
Grubbs SS, Polite BN, Carney J Jr, et al. Eliminating racial disparities in colorectal cancer in the real world: it took a village. J Clin Oncol. 2013;31(16):1928-1930. doi:10.1200/jco.2012.47.8412
Delaware Cancer Consortium. Delaware Cancer Consortium Accomplishments Report, June 2020: Turning vision into reality. Delaware Cancer Consortium; 2023. Accessed June 14, 2023. https://www.healthydelaware.org/Consortium/Resources-And-Reports#plans
George R, Gunn R, Wiggins N, et al. Early lessons and strategies from statewide efforts to integrate community health workers into Medicaid. J Health Care Poor Underserved. 2020;31(2):845-858. doi:10.1353/hpu.2020.0064
Tripoli S, Fishman E, Hewitt A, Ruff E, Sanders C. To Advance Health Equity, Federal Policy Makers Should Build on Lessons From State Medicaid Experiments. Health Affairs Blog.; April 14, 2021. Accessed August 29, 2023. https://familiesusa.org/resources/to-advance-health-equity-federal-policy-makers-should-build-on-lessons-from-state-medicaid-experiments/
Wright BJ, Royal N, Broffman L, Li HF, Dulacki K. Oregon's coordinated care organization experiment: are members' experiences of care actually changing? J Healthc Qual. 2019;41(4):e38-e46. doi:10.1097/jhq.0000000000000178
Livingston CJ, Bartelmann SE, Goff NM, Aird KG. Reducing tobacco use in Oregon through multisector collaboration: aligning Medicaid and public health programs. Prev Chronic Dis. 2020;17:E155. doi:10.5888/pcd17.200220
Kaiser Family Foundation. State Policies for Expanding Medicaid Coverage of Community Health Worker (CHW) Services. Kaiser Family Foundation; 2023. Accessed August 29, 2023. https://www.kff.org/medicaid/issue-brief/state-policies-for-expanding-medicaid-coverage-of-community-health-worker-chw-services/
Brown JJ, Asumeng CK, Greenwald D, et al. Decreased colorectal cancer incidence and mortality in a diverse urban population with increased colonoscopy screening. BMC Public Health. 2021;21(1):1280. doi:10.1186/s12889-021-11330-6
Haas JS, Lemon SC, Freund KM, Battagllia TA; Translating Research Into Practice (TRIP) Consortium Writing Group. Outside our walls: the case for city-wide collaboration to reduce disparities. J Gen Intern Med. 2021;36(1):211-213. doi:10.1007/s11606-020-06006-7
Simon MA, Fitzgibbon M, Ciecierski C, et al. Building cross-institutional collaborative infrastructure and processes: early lessons from the Chicago Cancer Health Equity Collaborative. Prog Community Health Partnersh. 2019;13:5-13. doi:10.1353/cpr.2019.0030
Itzkowitz SH, Winawer SJ, Krauskopf M, et al. New York Citywide Colon Cancer Control Coalition: a public health effort to increase colon cancer screening and address health disparities. Cancer. 2016;122(2):269-277. doi:10.1002/cncr.29595
117th Congress (2021-2022). H.R.1319-American Rescue Plan Act of 2021. Accessed May 5, 2023. https://www.congress.gov/bill/117th-congress/house-bill/1319/text
Keith K. American Rescue Plan increases ACA enrollment. Health Aff (Millwood). 2021;40(7):1026-1027. doi:10.1377/hlthaff.2021.00983
Kaiser Family Foundation. Five Things to Know about the Renewal of Extra Affordable Care Act Subsidies in the Inflation Reduction Act. Kaiser Family Foundation; 2023. Accessed May 5, 2023. https://www.kff.org/policy-watch/five-things-to-know-about-renewal-of-extra-affordable-care-act-subsidies-in-inflation-reduction-act/
Centers for Medicare & Medicaid Services (CMS). Inflation Reduction Act and Medicare. CMS; 2023. Accessed May 15, 2023. https://www.cms.gov/inflation-reduction-act-and-medicare
Centers for Medicare & Medicaid Services (CMS). Fact Sheet: Medicare Prescription Payment Plan. CMS; 2023. Accessed August 31, 2023. https://www.cms.gov/files/document/medicare-prescription-payment-plan-fact-sheet.pdf
Drope J, Liber AC, Cahn Z, et al. Who's still smoking? Disparities in adult cigarette smoking prevalence in the United States. CA Cancer J Clin. 2018;68(2):106-115. doi:10.3322/caac.21444
Lempert LK, Glantz SA. Tobacco industry promotional strategies targeting American Indians/Alaska Natives and exploiting tribal sovereignty. Nicotine Tob Res. 2019;21(7):940-948. doi:10.1093/ntr/nty048
Nguyen KH, Glantz SA, Palmer CN, Schmidt LA. Transferring racial/ethnic marketing strategies from tobacco to food corporations: Philip Morris and Kraft General Foods. Am J Public Health. 2020;110(3):329-336. doi:10.2105/ajph.2019.305482
Kalousova L, Levy D, Titus AR, et al. Cigarette taxes, prices, and disparities in current smoking in the United States. SSM Popul Health. 2020;12:100686. doi:10.1016/j.ssmph.2020.100686
Chaloupka FJ, Yurekli A, Fong GT. Tobacco taxes as a tobacco control strategy. Tob Control. 2012;21(2):172-180. doi:10.1136/tobaccocontrol-2011-050417
Chaloupka FJ, Powell LM, Warner KE. The use of excise taxes to reduce tobacco, alcohol, and sugary beverage consumption. Annu Rev Public Health. 2019;40(1):187-201. doi:10.1146/annurev-publhealth-040218-043816
Smith CE, Hill SE, Amos A. Impact of population tobacco control interventions on socioeconomic inequalities in smoking: a systematic review and appraisal of future research directions. Tob Control. 2020;30(e2):e87-e95. doi:10.1136/tobaccocontrol-2020-055874
Balbach ED, Gasior RJ, Barbeau EM. R.J. Reynolds' targeting of African Americans: 1988-2000. Am J Public Health. 2003;93(5):822-827. doi:10.2105/ajph.93.5.822
Goodwin RD, Ganz O, Weinberger AH, Smith PH, Wyka K, Delnevo CD. Menthol cigarette use among adults who smoke cigarettes, 2008-2020: rapid growth and widening inequities in the United States. Nicotine Tob Res. 2023;25(4):692-698. doi:10.1093/ntr/ntac214
Stephenson J. FDA outlines proposed ban on menthol cigarettes, flavored cigars. JAMA Health Forum. 2022;3(5):e221664. doi:10.1001/jamahealthforum.2022.1664
Furlow B. US FDA plans improved tobacco regulation. Lancet Respir Med. 2023;11(5):e48. doi:10.1016/s2213-2600(23)00103-0
Das M. Centers for Disease Control and Prevention invest in cancer prevention programmes. Lancet Oncol. 2022;23(7):e320. doi:10.1016/s1470-2045(22)00342-4
Bona K, Keating NL. Addressing social determinants of health: now is the time. J Natl Cancer Inst. 2022;114(12):1561-1563. doi:10.1093/jnci/djac137
Thornton RL, Glover CM, Cene CW, Glik DC, Henderson JA, Williams DR. Evaluating strategies for reducing health disparities by addressing the social determinants of health. Health Aff (Millwood). 2016;35(8):1416-1423. doi:10.1377/hlthaff.2015.1357
Mohan G, Chattopadhyay S. Cost-effectiveness of leveraging social determinants of health to improve breast, cervical, and colorectal cancer screening: a systematic review. JAMA Oncol. 2020;6(9):1434-1444. doi:10.1001/jamaoncol.2020.1460
Emmons KM, Colditz GA. Realizing the potential of cancer prevention-the role of implementation science. N Engl J Med. 2017;376(10):986-990. doi:10.1056/nejmsb1609101
Haghighat S, Jiang C, El-Rifai W, Zaika A, Goldberg DS, Kumar S. Urgent need to mitigate disparities in federal funding for cancer research. J Natl Cancer Inst. Published online June 8, 2023. doi:10.1093/jnci/djad097
Nguyen KH, Trivedi AN, Shireman TI. Lesbian, gay, and bisexual adults report continued problems affording care despite coverage gains. Health Aff (Millwood). 2018;37(8):1306-1312. doi:10.1377/hlthaff.2018.0281
Charlton BM, Gordon AR, Reisner SL, Sarda V, Samnaliev M, Austin SB. Sexual orientation-related disparities in employment, health insurance, healthcare access and health-related quality of life: a cohort study of US male and female adolescents and young adults. BMJ Open. 2018;8(6):e020418. doi:10.1136/bmjopen-2017-020418
Leone AG, Trapani D, Schabath MB, et al. Cancer in transgender and gender-diverse persons: a review. JAMA Oncol. 2023;9(4):556. doi:10.1001/jamaoncol.2022.7173
Steele CB, Townsend JS, Courtney-Long EA, Young M. Prevalence of cancer screening among adults with disabilities, United States, 2013. Prev Chronic Dis. 2017;14:E09. doi:10.5888/pcd14.160312
Edwards DJ, Sakellariou D, Anstey S. Barriers to, and facilitators of, access to cancer services and experiences of cancer care for adults with a physical disability: a mixed methods systematic review. Disabil Health J. 2020;13(1):100844. doi:10.1016/j.dhjo.2019.100844
Agaronnik N, El-Jawahri A, Iezzoni L. Implications of physical access barriers for breast cancer diagnosis and treatment in women with mobility disability. J Disabil Policy Stud. 2022;33(1):46-54. doi:10.1177/10442073211010124
Velepucha-Iniguez J, Bonilla Sierra P, Bruera E. Barriers to palliative care access in patients with intellectual disability: a scoping review. J Pain Symptom Manag. 2022;64(6):e347-e356. doi:10.1016/j.jpainsymman.2022.08.007
Kushalnagar P, Hill C, Carrizales S, Sadler GR. Prostate-specimen antigen (PSA) screening and shared decision making among deaf and hearing male patients. J Cancer Educ. 2020;35(1):28-35. doi:10.1007/s13187-018-1436-3
Long JC, Delamater PL, Holmes GM. Which definition of rurality should I use? The relative performance of 8 federal rural definitions in identifying rural-urban disparities. Med Care. 2021;59(suppl 5):S413-S419. doi:10.1097/mlr.0000000000001612
Akinbami LJ, Chen TC, Davy O, et al. National Health and Nutrition Examination Survey, 2017-March 2020 Prepandemic File: sample design, estimation, and analytic guidelines. Vital Health Stat. 2022;190:1-36.